Click for best price
DPP4 Inhibitor Hypoglycemic Drugs Market Size, Share 2024
The global DPP-4 Inhibitor Hypoglycemic Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Sitagliptin Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of DPP-4 Inhibitor Hypoglycemic Drugs include Merck, MSD Pharma, Novartis, AstraZeneca Pharmaceuticals, Takeda Pharmaceutical, Boehringer Ingelheim International, Huahai Pharmaceutical, Langnuo Pharmaceutical and QILU Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
DPP-4 inhibitor hypoglycemic drugs can not only reduce the blood sugar concentration of patients, but also promote insulin secretion, and even repair damaged islet cells. Compared with traditional hypoglycemic drugs, they have many advantages such as high efficacy and low side effects.
This report aims to provide a comprehensive presentation of the global market for DPP-4 Inhibitor Hypoglycemic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPP-4 Inhibitor Hypoglycemic Drugs. This report contains market size and forecasts of DPP-4 Inhibitor Hypoglycemic Drugs in global, including the following market information:
Global DPP-4 Inhibitor Hypoglycemic Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global DPP-4 Inhibitor Hypoglycemic Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five DPP-4 Inhibitor Hypoglycemic Drugs companies in 2023 (%)
We has surveyed the DPP-4 Inhibitor Hypoglycemic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DPP-4 Inhibitor Hypoglycemic Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs Market Segment Percentages, by Type, 2023 (%)
Sitagliptin
Vildagliptin
Saxagliptin
Alogliptin
Linagliptin
Others
Global DPP-4 Inhibitor Hypoglycemic Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global DPP-4 Inhibitor Hypoglycemic Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global DPP-4 Inhibitor Hypoglycemic Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DPP-4 Inhibitor Hypoglycemic Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies DPP-4 Inhibitor Hypoglycemic Drugs revenues share in global market, 2023 (%)
Key companies DPP-4 Inhibitor Hypoglycemic Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies DPP-4 Inhibitor Hypoglycemic Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
MSD Pharma
Novartis
AstraZeneca Pharmaceuticals
Takeda Pharmaceutical
Boehringer Ingelheim International
Huahai Pharmaceutical
Langnuo Pharmaceutical
QILU Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Gan & Lee Pharmaceuticals
Kelun Pharmaceutical
YOKO Pharmaceutical
Disainuo Pharmaceutical
Reyoung Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of DPP-4 Inhibitor Hypoglycemic Drugs, market overview.
Chapter 2: Global DPP-4 Inhibitor Hypoglycemic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of DPP-4 Inhibitor Hypoglycemic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DPP-4 Inhibitor Hypoglycemic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global DPP-4 Inhibitor Hypoglycemic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
DPP-4 Inhibitor Hypoglycemic Drugs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 DPP-4 Inhibitor Hypoglycemic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DPP-4 Inhibitor Hypoglycemic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global DPP-4 Inhibitor Hypoglycemic Drugs Overall Market Size
2.1 Global DPP-4 Inhibitor Hypoglycemic Drugs Market Size: 2023 VS 2030
2.2 Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global DPP-4 Inhibitor Hypoglycemic Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top DPP-4 Inhibitor Hypoglycemic Drugs Players in Global Market
3.2 Top Global DPP-4 Inhibitor Hypoglycemic Drugs Companies Ranked by Revenue
3.3 Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue by Companies
3.4 Global DPP-4 Inhibitor Hypoglycemic Drugs Sales by Companies
3.5 Global DPP-4 Inhibitor Hypoglycemic Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 DPP-4 Inhibitor Hypoglycemic Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 DPP-4 Inhibitor Hypoglycemic Drugs Players in Global Market
3.8.1 List of Global Tier 1 DPP-4 Inhibitor Hypoglycemic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 DPP-4 Inhibitor Hypoglycemic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Market Size Markets, 2023 & 2030
4.1.2 Sitagliptin
4.1.3 Vildagliptin
4.1.4 Saxagliptin
4.1.5 Alogliptin
4.1.6 Linagliptin
4.1.7 Others
4.2 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue & Forecasts
4.2.1 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2024
4.2.2 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2025-2030
4.2.3 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales & Forecasts
4.3.1 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2024
4.3.2 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2025-2030
4.3.3 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
4.4 By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue & Forecasts
5.2.1 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2024
5.2.2 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2025-2030
5.2.3 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales & Forecasts
5.3.1 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2024
5.3.2 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2025-2030
5.3.3 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
5.4 By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2023 & 2030
6.2 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue & Forecasts
6.2.1 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2024
6.2.2 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2025-2030
6.2.3 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales & Forecasts
6.3.1 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2024
6.3.2 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2025-2030
6.3.3 By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2030
6.4.2 By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2030
6.4.3 US DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.4.4 Canada DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.4.5 Mexico DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2030
6.5.2 By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2030
6.5.3 Germany DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5.4 France DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5.5 U.K. DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5.6 Italy DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5.7 Russia DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5.8 Nordic Countries DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.5.9 Benelux DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2030
6.6.2 By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2030
6.6.3 China DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.6.4 Japan DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.6.5 South Korea DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.6.6 Southeast Asia DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.6.7 India DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2030
6.7.2 By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2030
6.7.3 Brazil DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.7.4 Argentina DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Sales, 2019-2030
6.8.3 Turkey DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.8.4 Israel DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
6.8.6 UAE DPP-4 Inhibitor Hypoglycemic Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.1.4 Merck DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 MSD Pharma
7.2.1 MSD Pharma Company Summary
7.2.2 MSD Pharma Business Overview
7.2.3 MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.2.4 MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.2.5 MSD Pharma Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.3.4 Novartis DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 AstraZeneca Pharmaceuticals
7.4.1 AstraZeneca Pharmaceuticals Company Summary
7.4.2 AstraZeneca Pharmaceuticals Business Overview
7.4.3 AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.4.4 AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.4.5 AstraZeneca Pharmaceuticals Key News & Latest Developments
7.5 Takeda Pharmaceutical
7.5.1 Takeda Pharmaceutical Company Summary
7.5.2 Takeda Pharmaceutical Business Overview
7.5.3 Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.5.4 Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Takeda Pharmaceutical Key News & Latest Developments
7.6 Boehringer Ingelheim International
7.6.1 Boehringer Ingelheim International Company Summary
7.6.2 Boehringer Ingelheim International Business Overview
7.6.3 Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Boehringer Ingelheim International Key News & Latest Developments
7.7 Huahai Pharmaceutical
7.7.1 Huahai Pharmaceutical Company Summary
7.7.2 Huahai Pharmaceutical Business Overview
7.7.3 Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.7.4 Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Huahai Pharmaceutical Key News & Latest Developments
7.8 Langnuo Pharmaceutical
7.8.1 Langnuo Pharmaceutical Company Summary
7.8.2 Langnuo Pharmaceutical Business Overview
7.8.3 Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.8.4 Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Langnuo Pharmaceutical Key News & Latest Developments
7.9 QILU Pharmaceutical
7.9.1 QILU Pharmaceutical Company Summary
7.9.2 QILU Pharmaceutical Business Overview
7.9.3 QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.9.4 QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.9.5 QILU Pharmaceutical Key News & Latest Developments
7.10 Chia Tai-Tianqing Pharmaceutical
7.10.1 Chia Tai-Tianqing Pharmaceutical Company Summary
7.10.2 Chia Tai-Tianqing Pharmaceutical Business Overview
7.10.3 Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.10.4 Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Chia Tai-Tianqing Pharmaceutical Key News & Latest Developments
7.11 Gan & Lee Pharmaceuticals
7.11.1 Gan & Lee Pharmaceuticals Company Summary
7.11.2 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Business Overview
7.11.3 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.11.4 Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Gan & Lee Pharmaceuticals Key News & Latest Developments
7.12 Kelun Pharmaceutical
7.12.1 Kelun Pharmaceutical Company Summary
7.12.2 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Business Overview
7.12.3 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.12.4 Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Kelun Pharmaceutical Key News & Latest Developments
7.13 YOKO Pharmaceutical
7.13.1 YOKO Pharmaceutical Company Summary
7.13.2 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Business Overview
7.13.3 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.13.4 YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.13.5 YOKO Pharmaceutical Key News & Latest Developments
7.14 Disainuo Pharmaceutical
7.14.1 Disainuo Pharmaceutical Company Summary
7.14.2 Disainuo Pharmaceutical Business Overview
7.14.3 Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.14.4 Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Disainuo Pharmaceutical Key News & Latest Developments
7.15 Reyoung Pharmaceutical
7.15.1 Reyoung Pharmaceutical Company Summary
7.15.2 Reyoung Pharmaceutical Business Overview
7.15.3 Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Major Product Offerings
7.15.4 Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Reyoung Pharmaceutical Key News & Latest Developments
8 Global DPP-4 Inhibitor Hypoglycemic Drugs Production Capacity, Analysis
8.1 Global DPP-4 Inhibitor Hypoglycemic Drugs Production Capacity, 2019-2030
8.2 DPP-4 Inhibitor Hypoglycemic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global DPP-4 Inhibitor Hypoglycemic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DPP-4 Inhibitor Hypoglycemic Drugs Supply Chain Analysis
10.1 DPP-4 Inhibitor Hypoglycemic Drugs Industry Value Chain
10.2 DPP-4 Inhibitor Hypoglycemic Drugs Upstream Market
10.3 DPP-4 Inhibitor Hypoglycemic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 DPP-4 Inhibitor Hypoglycemic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of DPP-4 Inhibitor Hypoglycemic Drugs in Global Market
Table 2. Top DPP-4 Inhibitor Hypoglycemic Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Share by Companies, 2019-2024
Table 5. Global DPP-4 Inhibitor Hypoglycemic Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers DPP-4 Inhibitor Hypoglycemic Drugs Product Type
Table 9. List of Global Tier 1 DPP-4 Inhibitor Hypoglycemic Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DPP-4 Inhibitor Hypoglycemic Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Sales, (K Units), 2025-2030
Table 46. Merck Company Summary
Table 47. Merck DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 48. Merck DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. MSD Pharma Company Summary
Table 51. MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 52. MSD Pharma DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. MSD Pharma Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 56. Novartis DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Novartis Key News & Latest Developments
Table 58. AstraZeneca Pharmaceuticals Company Summary
Table 59. AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 60. AstraZeneca Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. AstraZeneca Pharmaceuticals Key News & Latest Developments
Table 62. Takeda Pharmaceutical Company Summary
Table 63. Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 64. Takeda Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Takeda Pharmaceutical Key News & Latest Developments
Table 66. Boehringer Ingelheim International Company Summary
Table 67. Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 68. Boehringer Ingelheim International DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Boehringer Ingelheim International Key News & Latest Developments
Table 70. Huahai Pharmaceutical Company Summary
Table 71. Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 72. Huahai Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Huahai Pharmaceutical Key News & Latest Developments
Table 74. Langnuo Pharmaceutical Company Summary
Table 75. Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 76. Langnuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Langnuo Pharmaceutical Key News & Latest Developments
Table 78. QILU Pharmaceutical Company Summary
Table 79. QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 80. QILU Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. QILU Pharmaceutical Key News & Latest Developments
Table 82. Chia Tai-Tianqing Pharmaceutical Company Summary
Table 83. Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 84. Chia Tai-Tianqing Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Chia Tai-Tianqing Pharmaceutical Key News & Latest Developments
Table 86. Gan & Lee Pharmaceuticals Company Summary
Table 87. Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 88. Gan & Lee Pharmaceuticals DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Gan & Lee Pharmaceuticals Key News & Latest Developments
Table 90. Kelun Pharmaceutical Company Summary
Table 91. Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 92. Kelun Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Kelun Pharmaceutical Key News & Latest Developments
Table 94. YOKO Pharmaceutical Company Summary
Table 95. YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 96. YOKO Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. YOKO Pharmaceutical Key News & Latest Developments
Table 98. Disainuo Pharmaceutical Company Summary
Table 99. Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 100. Disainuo Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Disainuo Pharmaceutical Key News & Latest Developments
Table 102. Reyoung Pharmaceutical Company Summary
Table 103. Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Product Offerings
Table 104. Reyoung Pharmaceutical DPP-4 Inhibitor Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Reyoung Pharmaceutical Key News & Latest Developments
Table 106. DPP-4 Inhibitor Hypoglycemic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global DPP-4 Inhibitor Hypoglycemic Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global DPP-4 Inhibitor Hypoglycemic Drugs Production by Region, 2019-2024 (K Units)
Table 109. Global DPP-4 Inhibitor Hypoglycemic Drugs Production by Region, 2025-2030 (K Units)
Table 110. DPP-4 Inhibitor Hypoglycemic Drugs Market Opportunities & Trends in Global Market
Table 111. DPP-4 Inhibitor Hypoglycemic Drugs Market Drivers in Global Market
Table 112. DPP-4 Inhibitor Hypoglycemic Drugs Market Restraints in Global Market
Table 113. DPP-4 Inhibitor Hypoglycemic Drugs Raw Materials
Table 114. DPP-4 Inhibitor Hypoglycemic Drugs Raw Materials Suppliers in Global Market
Table 115. Typical DPP-4 Inhibitor Hypoglycemic Drugs Downstream
Table 116. DPP-4 Inhibitor Hypoglycemic Drugs Downstream Clients in Global Market
Table 117. DPP-4 Inhibitor Hypoglycemic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. DPP-4 Inhibitor Hypoglycemic Drugs Segment by Type in 2023
Figure 2. DPP-4 Inhibitor Hypoglycemic Drugs Segment by Application in 2023
Figure 3. Global DPP-4 Inhibitor Hypoglycemic Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global DPP-4 Inhibitor Hypoglycemic Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. DPP-4 Inhibitor Hypoglycemic Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by DPP-4 Inhibitor Hypoglycemic Drugs Revenue in 2023
Figure 9. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global DPP-4 Inhibitor Hypoglycemic Drugs Price (US$/Unit), 2019-2030
Figure 13. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global DPP-4 Inhibitor Hypoglycemic Drugs Price (US$/Unit), 2019-2030
Figure 17. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 23. US DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 28. Germany DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 37. China DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 44. Brazil DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa DPP-4 Inhibitor Hypoglycemic Drugs Sales Market Share, 2019-2030
Figure 48. Turkey DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE DPP-4 Inhibitor Hypoglycemic Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global DPP-4 Inhibitor Hypoglycemic Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production DPP-4 Inhibitor Hypoglycemic Drugs by Region, 2023 VS 2030
Figure 54. DPP-4 Inhibitor Hypoglycemic Drugs Industry Value Chain
Figure 55. Marketing Channels
